Invivyd, Inc. Common Stock
$0.76
Market Cap
$222.63M
Shares Outstanding
294.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 6, 2021
Round Lot
100
Locale
US
Day Open
$0.76
Day High
$0.79
Day Low
$0.73
Volume
6.28M
VWAP
$0.76
Prev Close
$0.75
Transactions
--
Acc. Volume
--
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
Invivyd, Inc. Common Stock (IVVD) closed the 2026-09-18 session at $0.76, up 1.22% versus the previous close (+0.01). The stock opened at $0.76 and traded between $0.73 and $0.79 during that session. Session trading volume was 6.3M shares. The volume-weighted average price (VWAP) is $0.76.
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
Invivyd, Inc. Common Stock has a market capitalization of $222.6 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. IVVD is listed on the XNAS exchange. The company employs approximately 122 people. Invivyd, Inc. Common Stock is headquartered in NEW HAVEN, CT. The recorded listing date is 2021-08-06.
On this page you can find market IVVD stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.